139 related articles for article (PubMed ID: 23086570)
1. Step-up/step-down perfusion approach for increased mAb 520C9 production by a hybridoma cell line.
Sen S; Roychoudhury PK
Biotechnol Lett; 2013 Feb; 35(2):153-63. PubMed ID: 23086570
[TBL] [Abstract][Full Text] [Related]
2. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
Tang YJ; Ohashi R; Hamel JF
Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
[TBL] [Abstract][Full Text] [Related]
3. A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells.
Dong H; Tang YJ; Ohashi R; Hamel JF
Biotechnol Prog; 2005; 21(1):140-7. PubMed ID: 15903251
[TBL] [Abstract][Full Text] [Related]
4. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
Seifert DB; Phillips JA
Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
[TBL] [Abstract][Full Text] [Related]
5. On-line purification of monoclonal antibodies using an integrated stirred-tank reactor/expanded-bed adsorption system.
Ohashi R; Otero JM; Chwistek A; Yamato I; Hamel JF
Biotechnol Prog; 2002; 18(6):1292-300. PubMed ID: 12467465
[TBL] [Abstract][Full Text] [Related]
6. Production of monoclonal antibodies for breast cancer by HB8696 hybridoma cells using novel perfusion system.
Kamthan S; Gomes J; Roychoudhury PK
Enzyme Microb Technol; 2014 Oct; 64-65():44-51. PubMed ID: 25152416
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody production using a new supermacroporous cryogel bioreactor.
Nilsang S; Nandakumar KS; Galaev IY; Rakshit SK; Holmdahl R; Mattiasson B; Kumar A
Biotechnol Prog; 2007; 23(4):932-9. PubMed ID: 17590012
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting monoclonal antibody production in culture.
Reuveny S; Velez D; Macmillan JD; Miller L
Dev Biol Stand; 1987; 66():169-75. PubMed ID: 3582746
[TBL] [Abstract][Full Text] [Related]
9. An empirical modeling platform to evaluate the relative control discrete CHO cell synthetic processes exert over recombinant monoclonal antibody production process titer.
McLeod J; O'Callaghan PM; Pybus LP; Wilkinson SJ; Root T; Racher AJ; James DC
Biotechnol Bioeng; 2011 Sep; 108(9):2193-204. PubMed ID: 21445882
[TBL] [Abstract][Full Text] [Related]
10. Continuous production of monoclonal antibody in a packed-bed bioreactor.
Golmakany N; Rasaee MJ; Furouzandeh M; Shojaosadati SA; Kashanian S; Omidfar K
Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):273-8. PubMed ID: 15506916
[TBL] [Abstract][Full Text] [Related]
11. Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity.
Tey BT; Al-Rubeai M
Apoptosis; 2004 Nov; 9(6):843-52. PubMed ID: 15505426
[TBL] [Abstract][Full Text] [Related]
12. Integrated continuous production of recombinant therapeutic proteins.
Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
[TBL] [Abstract][Full Text] [Related]
13. Cooverexpression of alanine aminotransferase 1 in Chinese hamster ovary cells overexpressing taurine transporter further stimulates metabolism and enhances product yield.
Tabuchi H; Sugiyama T
Biotechnol Bioeng; 2013 Aug; 110(8):2208-15. PubMed ID: 23436610
[TBL] [Abstract][Full Text] [Related]
14. High-level production of a monoclonal antibody in murine myeloma cells by perfusion culture using a gravity settler.
Choo CY; Tian Y; Kim WS; Blatter E; Conary J; Brady CP
Biotechnol Prog; 2007; 23(1):225-31. PubMed ID: 17269692
[TBL] [Abstract][Full Text] [Related]
15. Effect of feed and bleed rate on hybridoma cells in an acoustic perfusion bioreactor: part I. Cell density, viability, and cell-cycle distribution.
Dalm MC; Cuijten SM; van Grunsven WM; Tramper J; Martens DE
Biotechnol Bioeng; 2004 Dec; 88(5):547-57. PubMed ID: 15459904
[TBL] [Abstract][Full Text] [Related]
16. High productivity of human recombinant beta-interferon from a low-temperature perfusion culture.
Rodriguez J; Spearman M; Tharmalingam T; Sunley K; Lodewyks C; Huzel N; Butler M
J Biotechnol; 2010 Dec; 150(4):509-18. PubMed ID: 20933553
[TBL] [Abstract][Full Text] [Related]
17. High cell density fed batch and perfusion processes for stable non-viral expression of secreted alkaline phosphatase (SEAP) using insect cells: comparison to a batch Sf-9-BEV system.
Jardin BA; Montes J; Lanthier S; Tran R; Elias C
Biotechnol Bioeng; 2007 Jun; 97(2):332-45. PubMed ID: 17054119
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional culture for monoclonal antibody production by hybridoma cells immobilized in macroporous gel particles.
Nilsang S; Nehru V; Plieva FM; Nandakumar KS; Rakshit SK; Holmdahl R; Mattiasson B; Kumar A
Biotechnol Prog; 2008; 24(5):1122-31. PubMed ID: 19194922
[TBL] [Abstract][Full Text] [Related]
19. Bcl-x(L) mediates increased production of humanized monoclonal antibodies in Chinese hamster ovary cells.
Chiang GG; Sisk WP
Biotechnol Bioeng; 2005 Sep; 91(7):779-92. PubMed ID: 15986489
[TBL] [Abstract][Full Text] [Related]
20. Application of "oxygen uptake rate-amino acids" associated mode in controlled-fed perfusion culture.
Feng Q; Mi L; Li L; Liu R; Xie L; Tang H; Chen Z
J Biotechnol; 2006 Apr; 122(4):422-30. PubMed ID: 16274826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
